Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ketty Hu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Revue Medicale Suisse|September 28, 2022
[A case of pyroglutamic metabolic acidosis after cotreatment by flucloxacillin and paracetamol]Adlija Desgranges, Ketty Hu, Carole Monney Chaubert
Revue Medicale Suisse|October 17, 2025
[HPV self-sampling and cervical cancer screening]Micol Murtas, Louise Rolland-Guillard, Ketty Hu, et al.
International Journal of Cancer|June 18, 2026
Resource-Adapted Triage Strategies for Women Testing HPV Positive With Self-Collected Vaginal Samples in CameroonMicol Murtas, Pierre Vassilakos, Ania Wisniak, et al.
Familial Cancer|April 29, 2023
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literatureKetty Hu-Heimgartner, Noémie Lang, Aurélie Ayme, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Revue Medicale Suisse|September 28, 2022
[A case of pyroglutamic metabolic acidosis after cotreatment by flucloxacillin and paracetamol]Adlija Desgranges, Ketty Hu, Carole Monney Chaubert
Revue Medicale Suisse|October 17, 2025
[HPV self-sampling and cervical cancer screening]Micol Murtas, Louise Rolland-Guillard, Ketty Hu, et al.
International Journal of Cancer|June 18, 2026
Resource-Adapted Triage Strategies for Women Testing HPV Positive With Self-Collected Vaginal Samples in CameroonMicol Murtas, Pierre Vassilakos, Ania Wisniak, et al.
Familial Cancer|April 29, 2023
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literatureKetty Hu-Heimgartner, Noémie Lang, Aurélie Ayme, et al.
Pageof 1